Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
Author(s) -
William C. Knowler,
Elizabeth BarrettConnor,
Sarah Fowler,
Richard F. Hamman,
John M. Lachin,
Elizabeth A. Walker,
David M. Nathan
Publication year - 2002
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa012512
Subject(s) - metformin , medicine , overweight , type 2 diabetes , confidence interval , diabetes mellitus , placebo , body mass index , incidence (geometry) , weight loss , obesity , endocrinology , physics , alternative medicine , optics , pathology
Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors--elevated plasma glucose concentrations in the fasting state and after an oral glucose load, overweight, and a sedentary lifestyle--are potentially reversible. We hypothesized that modifying these factors with a lifestyle-intervention program or the administration of metformin would prevent or delay the development of diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom